The UAE is set to launch its first Medical Sector Summit, based on AI
The United Arab Emirates has announced that it is set to launch its first International Artificial Intelligence in the Medical Sector Summit this year.
The region is placing significant investment in its drive to become one of the top destinations for healthcare worldwide. With an increased awareness of how technology will play a key part in the industry’s transformation, the Summit will bring together experts, specialists and significant figures to discuss how the field will benefit from such developments, both at a national and international level.
- Optimising the care pathway – A vision of connected healthcare delivery
- AR, VR healthcare market to reach $3bn by 2023
- Fitbit acquires clinical coaching platform Twine Health
Held under the patronage of HH Sheikh bin Zayed Al Nahyan, Deputy Chairman of Abu Dhabi Executive Council, The Abu Dhabi Health Services Company (SEHA) is set to organise the Summit for the second half of the year, which will see the development of new digital solutions.
Dr. Matar Al Darmaki, CEO, Abu Dhabi Health Services Company (SEHA) said, “The Summit on artificial intelligence in the medical sector represents a strong push towards improving the quality and efficiency of the UAE health sector, to provide the best international medical practices and ideal healthcare for Emiratis and expatriate residents, as well as enhancing Abu Dhabi’s reputation as a global hub in the health sector.
“We are also confident of the positive impact resulting from adopting artificial intelligence in medical practices and meeting the growing needs of Abu Dhabi,” he added.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”